Hereditary Cancer Testing Market Report 2026
Download Free Sample Buy Now
Hereditary Cancer Testing Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Hereditary Cancer Testing Market Report 2026

Global Outlook – By Test Type (Multi Panel Test, Single-Site Genetic Test), By Indication (Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications), By End user (Hospital, Clinics, Diagnostic Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Hereditary Cancer Testing Market Overview

• Hereditary Cancer Testing market size has reached to $4.75 billion in 2025

• Expected to grow to $8.02 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%

• Growth Driver: Hereditary Cancer Testing's Crucial Role Amidst The Escalating Overall Cancer Burden

• Market Trend: Enhancing Patient Care Through Molecular Diagnostics

• North America was the largest region in 2025.

What Is Covered Under Hereditary Cancer Testing Market?

The hereditary cancer testing refers to testing methods for hereditary cancers that can identify specific hereditary cancer diseases and disease-related gene mutations. This testing may decrease the risk of developing particular cancer mutants, allowing for a more comprehensive cancer risk for patients. The primary purpose of this cancer testing is to detect hereditary cancer early and maximize patient health outcomes. This testing procedure assists in identifying cancers for which one has a genetic risk and allows them to receive preventive treatment.

The main types of tests for hereditary cancer are multi panel tests and single-site genetic tests. The multi-panel test refers to a hereditary cancer test that is used to detect many chemicals simultaneously. Panels come in a variety of types, from three-panel tests that look for three substances to five, seven, and 12-panel tests. The choice of conducting the required number of tests is up to the tester’s discretion. Hereditary cancer testing is conducted to detect breast cancer, ovarian cancer, colorectal cancer, and other indications that are used in hospitals, clinics, and diagnostic centers.

Hereditary Cancer Testing Market Global Report 2026 Market Report bar graph

What Is The Hereditary Cancer Testing Market Size and Share 2026?

The hereditary cancer testing market size has grown rapidly in recent years. It will grow from $4.75 billion in 2025 to $5.3 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing awareness of hereditary cancer risks, availability of next-generation sequencing platforms, expansion of diagnostic laboratory networks, rising physician recommendation for genetic testing, growth of personalized risk assessment models.

What Is The Hereditary Cancer Testing Market Growth Forecast?

The hereditary cancer testing market size is expected to see rapid growth in the next few years. It will grow to $8.02 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to expansion of population-scale genetic screening, increasing use of ai-driven genomic analysis, growth in preventive oncology initiatives, rising demand for cost-effective testing solutions, enhanced regulatory support for genetic diagnostics. Major trends in the forecast period include increasing adoption of multi-gene panel testing, rising demand for early cancer risk detection, growing use of advanced genetic sequencing technologies, expansion of preventive testing programs, enhanced integration of clinical decision support tools.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Hereditary Cancer Testing Market Segmentation

1) By Test Type: Multi Panel Test, Single-Site Genetic Test

2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications

3) By End user: Hospital, Clinics, Diagnostic Centers

Subsegments:

1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels

2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing

What Is The Driver Of The Hereditary Cancer Testing Market?

An increase in the overall cancer burden is expected to propel the hereditary cancer testing market going forward. Cancer is a group of diseases characterized by the uncontrolled and abnormal growth of cells, which can invade and spread to other tissues and parts of the body. In a healthy organism, cells follow a regulated process of growth, division, and death. Hereditary cancer testing plays a critical role in addressing the overall burden of cancer by identifying individuals with a genetic predisposition to certain cancers. By assessing inherited mutations and familial risk factors, this testing helps identify individuals at higher risk, enabling early intervention, personalized treatment plans, and proactive preventive measures. For instance, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in Australia the number of cancer cases diagnosed increased from 160,570 in 2022 to 164,694 in 2023, reflecting a notable rise over the year. This upward trend highlights the growing prevalence of cancer within the country. Therefore, an increase in the overall cancer burden is driving the hereditary cancer testing industry.

Key Players In The Global Hereditary Cancer Testing Market

Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.

Global Hereditary Cancer Testing Market Trends and Insights

Major companies operating in the hereditary cancer testing market are focusing on innovative technologies, such as molecular diagnostic tumor testing, to enhance accuracy, improve patient outcomes, and personalize treatment strategies. Molecular diagnostic tumor testing involves analyzing a tumor's genetic and molecular characteristics to inform treatment decisions and predict outcomes. For instance, in February 2023, Chubb Business Services India Private Limited, an India-based global insurance company, launched Cancer Advocate Plus. The program includes genetics-based testing to identify inherited genes that increase cancer risk. This proactive approach allows individuals to understand their susceptibility to various cancers, facilitating early intervention and personalized care strategies.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Hereditary Cancer Testing Market?

In March 2024, Ambry Genetics, a US-based genetic testing company, formed a collaboration with Tempus AI, to offer integrated germline and somatic testing services. The collaboration aims to enhance access to comprehensive genomic insights, improve the accuracy of cancer diagnostics, and support personalized treatment strategies, while advancing innovation and growth in the molecular diagnostics market. Tempus AI is a US-based technology-driven precision medicine company specializes in leveraging data and technology to accelerate precision medicine and optimize patient care.

Regional Outlook

North America was the largest region in the hereditary cancer testing market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hereditary Cancer Testing Market?

The hereditary cancer testing market includes revenues earned by entities by providing hereditary cancer testing for lung cancer, cervical cancer, prostate cancer, stomach/gastric cancer, melanoma, sarcoma, and uterine cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hereditary Cancer Testing Market Report 2026?

The hereditary cancer testing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hereditary cancer testing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Hereditary Cancer Testing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $5.3 billion
Revenue Forecast In 2035 $8.02 billion
Growth Rate CAGR of 11.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Test Type, Indication, End user
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Hereditary Cancer Testing Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Hereditary Cancer Testing Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Hereditary Cancer Testing Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Hereditary Cancer Testing Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Multi-Gene Panel Testing

4.2.2 Rising Demand For Early Cancer Risk Detection

4.2.3 Growing Use Of Advanced Genetic Sequencing Technologies

4.2.4 Expansion Of Preventive Testing Programs

4.2.5 Enhanced Integration Of Clinical Decision Support Tools

5. Hereditary Cancer Testing Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Diagnostic Centers

5.4 Oncology Centers

5.5 Research Laboratories

6. Hereditary Cancer Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hereditary Cancer Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Hereditary Cancer Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Hereditary Cancer Testing Market Size, Comparisons And Growth Rate Analysis

7.3. Global Hereditary Cancer Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Hereditary Cancer Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hereditary Cancer Testing Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hereditary Cancer Testing Market Segmentation

9.1. Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Multi Panel Test, Single-Site Genetic Test

9.2. Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications

9.3. Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Clinics, Diagnostic Centers

9.4. Global Hereditary Cancer Testing Market, Sub-Segmentation Of Multi Panel Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Comprehensive Genetic Panels, Targeted Gene Panels

9.5. Global Hereditary Cancer Testing Market, Sub-Segmentation Of Single-Site Genetic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Specific Gene Testing, Familial Mutation Testing

10. Hereditary Cancer Testing Market Regional And Country Analysis

10.1. Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hereditary Cancer Testing Market

11.1. Asia-Pacific Hereditary Cancer Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hereditary Cancer Testing Market

12.1. China Hereditary Cancer Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hereditary Cancer Testing Market

13.1. India Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hereditary Cancer Testing Market

14.1. Japan Hereditary Cancer Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hereditary Cancer Testing Market

15.1. Australia Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hereditary Cancer Testing Market

16.1. Indonesia Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hereditary Cancer Testing Market

17.1. South Korea Hereditary Cancer Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hereditary Cancer Testing Market

18.1. Taiwan Hereditary Cancer Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hereditary Cancer Testing Market

19.1. South East Asia Hereditary Cancer Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hereditary Cancer Testing Market

20.1. Western Europe Hereditary Cancer Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hereditary Cancer Testing Market

21.1. UK Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hereditary Cancer Testing Market

22.1. Germany Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hereditary Cancer Testing Market

23.1. France Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hereditary Cancer Testing Market

24.1. Italy Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hereditary Cancer Testing Market

25.1. Spain Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hereditary Cancer Testing Market

26.1. Eastern Europe Hereditary Cancer Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hereditary Cancer Testing Market

27.1. Russia Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hereditary Cancer Testing Market

28.1. North America Hereditary Cancer Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hereditary Cancer Testing Market

29.1. USA Hereditary Cancer Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hereditary Cancer Testing Market

30.1. Canada Hereditary Cancer Testing Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hereditary Cancer Testing Market

31.1. South America Hereditary Cancer Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hereditary Cancer Testing Market

32.1. Brazil Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hereditary Cancer Testing Market

33.1. Middle East Hereditary Cancer Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hereditary Cancer Testing Market

34.1. Africa Hereditary Cancer Testing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Hereditary Cancer Testing Market, Segmentation By Test Type, Segmentation By Indication, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hereditary Cancer Testing Market Regulatory and Investment Landscape

36. Hereditary Cancer Testing Market Competitive Landscape And Company Profiles

36.1. Hereditary Cancer Testing Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Hereditary Cancer Testing Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Hereditary Cancer Testing Market Company Profiles

36.3.1. Centogene NV Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Ambry Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. NeoGenomics Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

37. Hereditary Cancer Testing Market Other Major And Innovative Companies

PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc.

38. Global Hereditary Cancer Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hereditary Cancer Testing Market

40. Hereditary Cancer Testing Market High Potential Countries, Segments and Strategies

40.1 Hereditary Cancer Testing Market In 2030 - Countries Offering Most New Opportunities

40.2 Hereditary Cancer Testing Market In 2030 - Segments Offering Most New Opportunities

40.3 Hereditary Cancer Testing Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Hereditary Cancer Testing Market, Overview Of Key Products - Product Examples
  • Table 2: Global Hereditary Cancer Testing Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Hereditary Cancer Testing Market, Supply Chain Analysis
  • Table 4: Global Hereditary Cancer Testing Market, Major Raw Material Providers
  • Table 5: Global Hereditary Cancer Testing Market, Major Resource Providers
  • Table 6: Global Hereditary Cancer Testing Market, Major Manufacturers (Suppliers)
  • Table 7: Global Hereditary Cancer Testing Market, Major Distributors And Channel Partners
  • Table 8: Global Hereditary Cancer Testing Market, Key Technologies & Future Trends
  • Table 9: Global Hereditary Cancer Testing Market, Major Trends
  • Table 10: Global Hereditary Cancer Testing Market, Major End Users
  • Table 11: Global Hereditary Cancer Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Hereditary Cancer Testing Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Hereditary Cancer Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Hereditary Cancer Testing Market - TAM, US$ Billion, 2025
  • Table 15: Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Hereditary Cancer Testing Market, Sub-Segmentation Of Multi Panel Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Hereditary Cancer Testing Market, Sub-Segmentation Of Single-Site Genetic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Hereditary Cancer Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Hereditary Cancer Testing Market - Company Scoring Matrix
  • Table 96: Centogene NV Financial Performance
  • Table 97: Ambry Genetics Inc. Financial Performance
  • Table 98: Myriad Genetics Inc. Financial Performance
  • Table 99: NeoGenomics Laboratories Inc. Financial Performance
  • Table 100: Quest Diagnostics Financial Performance
  • Table 101: Global Hereditary Cancer Testing Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Hereditary Cancer Testing Market, Competitive Dashboard
  • Table 103: Global Hereditary Cancer Testing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Hereditary Cancer Testing Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030
  • Table 105: Global, Hereditary Cancer Testing Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 106: Global, Hereditary Cancer Testing Market Size Gain ($ Billion), Segmentation By End user, 2025 – 2030

List Of Figures

    Figure 1: Global Hereditary Cancer Testing Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Hereditary Cancer Testing Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Hereditary Cancer Testing Market, Supply Chain Analysis
  • Figure 4: Global Hereditary Cancer Testing Market, Major Raw Material Providers
  • Figure 5: Global Hereditary Cancer Testing Market, Major Resource Providers
  • Figure 6: Global Hereditary Cancer Testing Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Hereditary Cancer Testing Market, Major Distributors And Channel Partners
  • Figure 8: Global Hereditary Cancer Testing Market, Key Technologies & Future Trends
  • Figure 9: Global Hereditary Cancer Testing Market, Major Trends
  • Figure 10: Global Hereditary Cancer Testing Market, Major End Users
  • Figure 11: Global Hereditary Cancer Testing Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Hereditary Cancer Testing Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Hereditary Cancer Testing Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Hereditary Cancer Testing Market - TAM, US$ Billion, 2025
  • Figure 15: Global Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Hereditary Cancer Testing Market, Sub-Segmentation Of Multi Panel Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Hereditary Cancer Testing Market, Sub-Segmentation Of Single-Site Genetic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Hereditary Cancer Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Hereditary Cancer Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Hereditary Cancer Testing Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Hereditary Cancer Testing Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Hereditary Cancer Testing Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Hereditary Cancer Testing Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Hereditary Cancer Testing Market - Company Scoring Matrix
  • Figure 96: Centogene NV Financial Performance
  • Figure 97: Ambry Genetics Inc. Financial Performance
  • Figure 98: Myriad Genetics Inc. Financial Performance
  • Figure 99: NeoGenomics Laboratories Inc. Financial Performance
  • Figure 100: Quest Diagnostics Financial Performance
  • Figure 101: Global Hereditary Cancer Testing Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Hereditary Cancer Testing Market, Competitive Dashboard
  • Figure 103: Global Hereditary Cancer Testing Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Hereditary Cancer Testing Market Size Gain ($ Billion), Segmentation By Test Type, 2025 – 2030
  • Figure 105: Global, Hereditary Cancer Testing Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 106: Global, Hereditary Cancer Testing Market Size Gain ($ Billion), Segmentation By End user, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Anti-Money Laundering Market Report 2026 - Global Outlook – By Product (Compliance Management, Currency Transaction Reporting, Customer Identity Management, Transaction Monitoring), By Component (Software, Services), By ...

In-App Purchase Market Report 2026 - Global Outlook – By Type (Consumable, Non-Consumable, Subscription), By Operating System (Android, iOS, Other Operating Systems), By App Category (Gaming, Entertainment And Music, Hea...

Laryngeal Mask Market Report 2026 - Global Outlook – By Type (Reusable Laryngeal Masks, Disposable Laryngeal Masks), By Patient (Children, Adult, Geriatric), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, ...

Advance Directives Market Report 2026 - Global Outlook – By Component (Software, Services), By Demographics (Elderly Population (More Than 65 years), Middle Aged (40 To 64 years), Young Adults (18 To 39 years)), By End U...

Vegan Ice Cream Market Report 2026 - Global Outlook – By Source (Coconut Milk, Almond Milk, Cashew Milk, Soy Milk), By Product (Impulse, Artisanal, Take Home), By Form (Singles, Blends), By Flavor (Vanilla, Chocolate, Bu...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Application Server Software Platform Market Report 2026 - Global Outlook – By Type (Java-Based, Microsoft Windows-Based, Other Types), By Application (Deployment And Integration, Support And Maintenance), By End-User (Ba...

Myopia and Presbyopia Treatment Market Report 2026 - Global Outlook – By Type (Myopia, Presbyopia), By Age Group (Children And Young Adults, Adults, Geriatrics), By End-Use (Hospitals, Eye Care Clinics Or Ophthalmic Cent...

Frequently Asked Questions

The Hereditary Cancer Testing market was valued at $4.75 billion in 2025, increased to $5.3 billion in 2026, and is projected to reach $8.02 billion by 2030.

The global Hereditary Cancer Testing market is expected to grow at a CAGR of 10.9% from 2026 to 2035 to reach $8.02 billion by 2035.

Some Key Players in the Hereditary Cancer Testing market Include, Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc. .

Major trend in this market includes: Enhancing Patient Care Through Molecular Diagnostics. For further insights on this market. request a sample here

North America was the largest region in the hereditary cancer testing market in 2025. The regions covered in the hereditary cancer testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us